Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models (vol 132, pg 1, 2022)

被引：1
|
作者：
Qi, Ming
Fan, Shuran
Huang, Maohua
Pan, Jinghua
Li, Yong
Miao, Qun
Lyu, Wenyu
Li, Xiaobo
Deng, Lijuan
Qiu, Shenghui
Liu, Tongzheng
Deng, Weiqing
Chu, Xiaodong
Jiang, Chang
He, Wenzhuo
Xia, Liangping
Yang, Yunlong
Hong, Jian
Qi, Qi
Yin, Wenqian
Liu, Xiangning
Shi, Changzheng
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei
机构：
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2023年 / 133卷 / 03期
关键词：
D O I：
10.1172/JCI168771
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Targeting CDK1 and MEK/ERK overcomes apoptosis resistance in BRAFV600E human colorectal cancer cells
    Zhang, Peng
    Kawakami, Hisato
    Liu, Weizhen
    Zeng, Xiangyu
    Stebhardt, Klaus
    Tao, Kaixiong
    Huang, Shengbing
    Sinicrope, Frank A.
    CANCER RESEARCH, 2018, 78 (13)
  • [12] Preclinical evaluation of AGTR1-Targeting molecular probe for colorectal cancer imaging in orthotopic and liver metastasis mouse models
    Zhou, Kuncheng
    Li, Gang
    Pan, Rongbin
    Xin, Sulin
    Wen, Weijie
    Wang, Huiyi
    Luo, Chao
    Gu, Yueqing
    Tu, Yuanbiao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [13] KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration (vol 76, pg 967, 2022)
    Wang, H.
    Zhang, B.
    Li, R.
    Chen, J.
    Xu, G.
    Zhu, Y.
    HEPATOLOGY, 2023, 78 (06) : E106 - E106
  • [14] ROR1-targeting switchable CAR-T cells for cancer therapy(Vol 41, Pg 4104, 2022)
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2024, 43 (13) : 992 - 992
  • [15] Colorectal cancer cells-derived exosomal miR-188-3p promotes liver metastasis by creating a pre-metastatic niche via activation of hepatic stellate cells
    Li, Tao
    Li, Taiyuan
    Liang, Yahang
    Yuan, Yuli
    Liu, Yang
    Yao, Yao
    Lei, Xiong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [16] RETRACTED: miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1 (Retracted article. See vol. 36, pg. 705, 2021)
    Liu, Yong
    Zhang, Mei
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (06) : 398 - 404
  • [17] L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer (vol 1, pg 28, 2020)
    Ganesh, Karuna
    Basnet, Harihar
    Kaygusuz, Yasemin
    Laughney, Ashley M.
    He, Lan
    Sharma, Roshan
    O'Rourke, Kevin P.
    Reuter, Vincent P.
    Huang, Yun-Han
    Turkekul, Mesruh
    Er, Ekrem Emrah
    Masilionis, Ignas
    Manova-Todorova, Katia
    Weiser, Martin R.
    Saltz, Leonard B.
    Garcia-Aguilar, Julio
    Koche, Richard
    Lowe, Scott W.
    Pe'er, Dana
    Shia, Jinru
    Massague, Joan
    NATURE CANCER, 2020, 1 (11) : 1128 - 1128
  • [18] RETRACTION: Activation of Polymeric Nanoparticle Intracellular Targeting Overcomes Chemodrug Resistance in Human Primary Patient Breast Cancer Cells (Retraction of Vol 13, Pg 8153, 2018)
    Abou-El-Naga, A. M.
    Mutawa, G.
    El-Sherbiny, I. M.
    Mousa, S. A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 : 2555 - 2555
  • [19] RETRACTION: MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1 (vol 37, pg 1698, 2017) (Retraction of Vol 37, Pg 1698, 2017)
    Sun, Jie
    Zhang, Huanying
    Li, Liying
    Yu, Lianfeng
    Fu, Lifang
    ONCOLOGY REPORTS, 2023, 50 (02)
  • [20] CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer
    Tan, Hao-Xiang
    Gong, Wei-Zhi
    Zhou, Kai
    Xiao, Zhi-Gang
    Hou, Fu-Tao
    Huang, Tao
    Zhang, Ling
    Dong, Hong-Yu
    Zhang, Wei-Lin
    Liu, Yu
    Huang, Zhong-Cheng
    CANCER BIOLOGY & THERAPY, 2020, 21 (03) : 258 - 268
12345